Trial Details
COMPLETEDBasic Information
| Clinical ID | c2029 |
|---|---|
| Identifier | NCT04089514 |
| Trial Title | A Real-world Study of Imraldi® Use |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Arthritis, Rheumatoid (RA)|Axial Spondyloarthritis (axSpA)|Arthritis, Psoriatic (PsA)|Crohn's Disease (CD)|Colitis, Ulcerative (UC) |
| Interventions | DRUG: Adalimumab |
Participant Information
| Sponsor | Biogen |
|---|---|
| City | Bruges |
| Country/Region | Belgium |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2019-06-30 |
|---|---|
| Primary Completion Date | 2021-11-30 |
| Completion Date | 2021-11-30 |